Sun Pharmaceutical Industries Ltd. closed 11.02% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

After a consistent five-day rally, the market may consolidate, though the overall trend remains positive. Below are some ...

Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.

The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of ...

Branded generics may still dominate volumes, but the real value lies in consumer health. As margin pressures grow, Indian ...

The pharma sector is likely to maintain steady earnings. Most brokerages flag US business recovery as the key swing factor ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

Analysts believe the key question is whether India can be exempted from the pharma tariffs, given the better relationship ...

Sun Pharmaceutical Industries Ltd. closed 10.67% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

The stock market is showing signs of strength again, delighting investors. Analysts have selected 10 amazing stocks for ...

Nifty Pharma index sinks over 2% as Indian drugmakers face tariff heat; Gland, Aurobindo, Biocon, Sun Pharma among top losers ...